Accessibility Menu
SkyAI logo

SkyAI(NASDAQ) SKYA

Market Cap$59.25MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2022)-100%
5 YearN/A
1 Year-90%
1 Month+5%
$1.38
-2.82%
-0.04Today
After hours$1.37-$0.01 (-0.65%)
SkyAI last closing stock price
MetricPriceDate
Last closeUSD 1.372026-08-31
SkyAI stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+2.24%USD 1.342026-08-24
1 month+4.58%USD 1.312026-07-31
3 month-4.86%USD 1.442026-06-02
Year to date-32.51%USD 2.032025-12-31
1 year-89.89%USD 13.552025-08-29
3 year-99.97%USD 4,923.602023-09-01
Since inception-99.99%USD 13,926.152022-04-14

SkyAI Financials at a Glance

Market Cap

$59.25MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$2.50M

Net Income (TTM)

-$397.51M

EPS (TTM)

-$12.10

P/E Ratio

-0.11

Dividend

$0.00

Beta (Volatility)

0.00 (Low)

Price

$1.38

Volume

1,066

Open

$1.42

Previous Close

$1.37

Daily Range

$1.34 - $1.42

52-Week Range

$0.91 - $13.50

Estimated Earnings Date

Dec 2, 2026

SKYA News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About SkyAI

Sharps makes syringes for hospitals and clinics to safely deliver vaccines and medicines. The company also manages digital assets, mainly Solana, to generate income. Its products help healthcare providers reduce waste and improve safety.

Products and Services

  • Safety Syringes: Ultra-low waste syringes for vaccines and medicines; used by hospitals and clinics.
  • Securgard and Sologard Syringes: Syringe lines for safe drug delivery; target healthcare providers and medical supply firms.
  • Digital Asset Treasury: Manages Solana (SOL) digital assets; generates income primarily through staking.
  • Staking Services: Earns rewards by staking SOL with multiple validators, including Coinbase; supports treasury income.
  • Stablecoin Holdings: Holds USDC and USDT for liquidity and settlements; supports digital asset operations.

Growth and Expansion

  • In 2025, spun off Hungarian manufacturing subsidiary and exited in-house production.
  • Launched digital asset treasury strategy in August 2025, focusing on Solana.
  • Raised $411 million in August 2025 via PIPE offering, including cash and digital assets.
  • Started share repurchase program in 2025, authorizing up to $100 million.
  • Expanded product sales to both U.S. and international healthcare markets in 2025.

What Makes Sharps Stand Out

Sharps combines medical device sales with a digital asset treasury, a rare mix in healthcare. Its treasury is highly concentrated in Solana, with most assets staked for yield. The company uses strict risk controls and diversified custodians to manage digital asset exposure.

Five Things You Need to Know

  • Digital asset treasury made up approximately 97% of 2025 revenue.
  • Medical device sales began in 2025, contributing approximately 3% of revenue.
  • Operating loss was $269.7 million in 2025, up approximately 4,750% from 2024.
  • Unrealized loss on digital assets was $152.95 million in 2025.

Bottom Line

Sharps shifted from medical device manufacturing to a dual focus on device sales and digital asset management. The company’s evolution highlights adaptability and a unique approach to treasury management in healthcare.

AI Generated • Apr 16, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

55

CEO

Paul K. Danner, III, MBA

Website

www.theskyai.co

Headquarters

Melville, NY 11747, US

SKYA Financials

Key Financial Metrics (TTM)

Gross Margin

106.03%

Operating Margin

-752.77%

Net Income Margin

-15914.89%

Return on Equity

-153.83%

Return on Capital

-4.97%

Return on Assets

-247.90%

Earnings Yield

-9.09%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$59.25MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

43.25M

Volume

1.07K

Avg. Volume

322.36K

Financials (TTM)

Gross Profit

$2.65M

Operating Income

-$18.80M

EBITDA

-$275.08M

Operating Cash Flow

-$18.04M

Capital Expenditure

$1.96M

Free Cash Flow

-$16.09M

Cash & ST Invst.

$12.07M

Total Debt

$302.68K

SkyAI Performance Analysis

SkyAI annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31USD 0N/A
20232023-12-31USD 0N/A
20242024-12-31USD 0N/A
20252025-12-31USD 7,009,129N/A
SkyAI sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30N/A
Q42025-12-31-222.2%
Q12026-03-31288.6%
Q22026-06-301105.3%
SkyAI annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31USD -3,780.2812.6%
20232023-12-31USD -4,983.9931.8%
20242024-12-31USD -2,219.50-55.5%
20252025-12-31USD -11.12-99.5%
SkyAI sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q32025-09-30N/A
Q42025-12-3113.9%
Q12026-03-3168.1%
Q22026-06-3073.1%

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$2.32M

N/A

Gross Profit

$2.04M

N/A

Gross Margin

87.77%

N/A

Market Cap

$59.25MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$11.85M

N/A

Employees

5

N/A

Net Income

-$23.28M

N/A

EBITDA

-$5.95M

N/A

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

$12.07M

N/A

Total Debt

$302.68K

N/A

Accounts Receivable

$637.02K

N/A

Inventory

$173.48K

N/A

Long Term Debt

$167.00K

N/A

Short Term Debt

$135.69K

N/A

Return on Assets

-2.48%

N/A

Return on Invested Capital

-11.94%

N/A

Free Cash Flow

-$3.01M

N/A

Operating Cash Flow

-$3.00M

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
^GSPCS&P 500
$7,684.24-0.00%
^DJIDJI
$53,254.61-0.01%
^IXICNASDAQ
$26,319.55-0.00%
BTCBitcoin
$78,890.00-0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$71.92+0.00%
WETOWetour Robotics
$5.48-0.04%
BITOProShares Trust - ProShares Bitcoin ETF
$10.63+0.02%
INTCIntel
$89.51+0.00%

Questions About SKYA

What is the current price of SkyAI?

SkyAI is trading at $1.37 per share.

What is the 52-week range for SkyAI?

Over the past 52 weeks, SkyAI has traded between $0.91 and $13.50.

How much debt does SkyAI have?

As of the most recent reporting period, SkyAI reported total debt of $302.68K.

How much cash does SkyAI have on hand?

SkyAI reported $12.07M in cash and cash equivalents in its most recent financial results.

What is SkyAI’s dividend yield?

SkyAI does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services